Enter your login e-mail to the account
Search
Search parameters
Search results
- Disease of the eye and aging
prof. MUDr. Andrej Černák, DrSc., MUDr. Branislav Trnavec, MUDr. Jana Nekorancová, MUDr. Lucia Štúrová
(3–4/2013, Interdisciplinary consilium ) - Pulmonary arterial hypertension: a rare, serious, but treatable cause of exertional dyspnea
doc. MUDr. Eva Goncalvesová, CSc.
(4/2012, Review articles )
- Závislosť u ženy a muža, rozdiely v pohlaví
MUDr. Mária Martinove
(3/2003, Case reports )
- Inflammatory myofibroblastic tumor
MUDr. Veronika Marcinakova, MUDr. Hana Dittrichova, MUDr. Karel Franěk, MUDr. Pavel Hanek
(1/2019, Communication from practice )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - The complications of lung cancer diagnostic process
MUDr. Radka Cahajlová, MUDr. Marián Marták
(6/2014, Original articles & case reports ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
doc. MUDr. Peter Beržinec, CSc.
(6/2014, Information & comments ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - TREATMENT STRATEGIES FOR CHILDHOOD NON-HODGKIN LYMPHOMA
h. doc. MUDr. Eva Bubanská, CSc.
(2/2008, Review articles ) - Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Information & comments ) - NEW „MARKERS AND PROGNOSTIC FACTORS“ – THE SURGICAL PATHOLOGIST‘S VIEW
prof. MUDr. Štefan Galbavý, CSc.
(3/2006, Review articles ) - Správa zo zasadnutia Výboru Slovenskej onkologickej spoločnosti, 20. 12. 2010
Zapísal: doc. MUDr. Peter Beržinec, CSc.
(1/2011, Information & comments ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Cytogenetic and molecular cytogenetic methods in hemato-oncology
Mgr. Petra Nováková, MUDr. Denisa Ilenčíková, PhD.
(2/2010, Review articles ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Importance of immunohistochemistry and application of TTF-1 and napsin A in differential diagnosis of primary pulmonary adenocarcinomas and pulmonary metastases of extrapulmonary origins
MUDr. Adela Mikuľaková, MUDr. Zuzana Hríbiková
(2/2017, Review articles ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Pathology Update, Stockholm 2006
prof. MUDr. Štefan Galbavý, CSc.
(4/2006, Events ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Prophylaxis and treatment of lymphomatous central nervous system infiltration
MUDr. Alexander Wild, MUDr. Juliana Holasová
(3/2019, Main topic ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - The characteristics of lung cancer in young adults
MUDr. Peter Kasan, MUDr. Mária Černá, CSc., MUDr. Radka Cahajlová, MUDr. Marián Marták, MUDr. Milada Veselá, MUDr. Lucia Denková, MUDr. Zuzana Šviheľová-Lišková
(3/2016, Original articles & case reports ) - Comprehensive analysis of selected epidemiological indicators of lung cancer in the Slovak Republic in an interactive online environment
doc. RNDr. Martina Ondrušová, PhD., MPH, Ing. Martin Suchanský
(6/2021, Main topic ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Aktuálne možnosti diagnostiky a liečby pacientov s ALK+ NSCLC
Kolektív autorov
(S4/2020, Main topic ) - Data back Merck’s Keytruda for first-line NSCLC
doc. MUDr. Peter Beržinec, CSc.
(3/2016, Information & comments ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - The effectiveness of second-generation ALK-TKIs in advance non-small cell lung cancer
MUDr. Simona Laštíková, MUDr. Michal Urda, PhD., MUDr. Juraj Mazal, MUDr. Marek Lafférs
(6/2021, Case reports ) - Do we know the number of lung cancer patients in Slovakia?
doc. RNDr. PhDr. Martina Ondrušová, PhD., MPH, Ing. Martin Suchanský, MUDr. Bela Mriňáková, PhD., MPH, MHA, MUDr. Michal Urda
(4/2023, Original articles ) - Testing molecular biomarkers in the treatment and management of patients with lung cancer in Slovakia
RNDr. Regína Lohajová Behulová, PhD., RNDr. Romana Valenčíková, PhD., Dr. Med. Veronika Urbán
(S2/2023, Review articles ) - The turbulent evolution of treatment strategies for early-diagnosed NSCLC
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(S2/2023, Review articles ) - Role of pathologist in the diagnosis of cancer of unknown primary origin
doc. MUDr. Karol Kajo, PhD.
(4/2013, Main topic ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Správy z podujatia ASCO Chicago 2015
(4/2015, Events ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - Translačný výskum v onkológii – prvé skúsenosti Jednotky translačného výskumu
doc. MUDr. Jozef Mardiak, CSc., doc. MUDr. Michal Mego, PhD., RNDr. Daniela Svetlovská, PhD.
(5/2014, Review articles ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Správa z Best of ASCO® Slovakia 2016
MUDr. Mária Rečková
(4/2016, Events ) - Advances in the treatment of T-cell lymphomas
MUDr. Lucia Petríková, PhD., MUDr. Andrej Vranovský, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(6/2022, Main topic ) - Správa z IX. bardejovských onkologických dní
doc. MUDr. Mária Wagnerová, CSc.
(4/2016, Events ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - Diffuse large B-cell lymphoma in atypical locations
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2015, Spectrum ) - Particularities of non-Hodgkin´s lymphomas in children
MUDr. Ladislav Deák
(1/2016, Main topic ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - Úvodné slovo
MUDr. Radovan Barilla, PhD.
(1/2012, Editorial ) - Molecular pathology of diffuse large B-cell lymphoma – a review
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD., MUDr. Jozef Mičák
(2/2015, Spectrum ) - Best of ASCO Slovakia 2010
MUDr. Mária Rečková
(6/2010, Events ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Biology of malignant lymphomas
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD.
(2/2014, Main topic ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Primary cutaneous lymphomas
MUDr. Miriam Ladická
(2/2014, Main topic ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(2/2014, Information & comments ) - Classification of cutanoues malignant lymphomas according to recently published new WHO classification (2008)
prof. MUDr. Lukáš Plank, CSc., MUDr. Martina Bobrovská, MUDr. Eva Minariková, PhD., prof. MUDr. Juraj Péč, CSc.
(3/2009, Review articles ) - Novinky v onkológii
MUDr. Tomáš Šálek
(1/2018, Information & comments )
- Pharmacogenetics in practice of a clinical pharmacologist and a pharmacist
MUDr. Olga Bartošová, Ph.D., Prof. MUDr. Ondřej Slanař, Ph.D., PharmDr. Irena Netíková, Ph.D.
(3/2016, Clinical pharmacy )
- Contemporary approaches to genetic diagnostics in clinical oncology
RNDr. Regína Lohajová Behulová, PhD., Mgr. Michal Svoboda, RNDr. Aster Alemayehu, PhD., Mgr. Lukáš Šebest, PhD.
(2/2024, Main topic )